Radius Health Inc (RDUS) Up On Positive Trial Data: Should You Buy?

Pharmaceutical company Radius Health Inc (NASDAQ:RDUS), which concentrates on developing products designed to treat osteoporosis, saw its shares rise by more than 15% yesterday following the release of...

Keep Reading →